Tag: Press Releases,afatinib,squamous cell carcinoma test
-
VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy
Biodesix’ blood-based VeriStrat test helps identify squamous NSCLC patients for EGFR-TKI therapy